Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs

Scandinavian Journal of Gastroenterology

Volumn 31, Issue 4, 1996, Pages 339-344

  Meling, T R ^b   Aabakken, L ^b   Roseth A ^b   Osnes, M ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

Calprotectin; Drug adverse effects; Drugs; Endoscopy; Gastrointestinal toxicity; Non steroidal antiinflammatory

Indexed keywords

BIOLOGICAL MARKER; CALPROTECTIN; INDOMETACIN; LORNOXICAM; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ENDOSCOPY; ENTERITIS; FECES ANALYSIS; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN EXPERIMENT; MALE; MONITORING; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; VOLUNTEER;

EID: 0029918291     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609006407     Document Type: Article

References (29)

1. Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, Smethurst P, et al. Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology 1987;93: 480-9.
2. Collins AJ, Du Troit JA. Upper gastrointestinal findings and faecal occult blood in patients with rheumatic diseases taking nonsteroidal anti-inflammatory drugs. Br J Rheumatol 1987; 26:295-8.
3. Bjarnason I, Zanelli G, Prouse P, Smethurst P, Smith T, Levi S, et al. Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet 1987;2:711-4.
4. Fliedner SU, Cronkite EP, Robertson JS. Granulopoiesis, senescence and random loss of neutrophilic granulocytes in human beings. Blood 1964;24:404-14.
5. Segal AW, Ensell J, Munro JA, Sarner M. Indium 111 tagged leucocytes in the diagnosis of inflammatory bowel disease. Lancet 1981;2:230-2.
6. Saverymuttu SH, Peters AM, Lavender JP, Hodgson HJ, Chadwick VS. 111Indium autologous leucocytes in inflammatory bowel disease. Gut 1983;24:293-9.
7. Becker W, Fischbach W, Weppler M, Mosl B, Jacoby G, Börner W. Radiolabelled granulocytes in inflammatory bowel disease: diagnostic possibilities and clinical indications. Nucl Med Commun 1988;9:693-701.
8. Nelson RL, Subramanian K, Gasparaitis A, Abcarian H, Pavel DG. 111Indium labelled granulocyte scan in the diagnosis and management of acute inflammatory bowel disease. Dis Colon Rectum 1990;33:451-7.
9. Pullman WE, Sullivan PJ, Barratt PJ, Lising J, Booth JA, Doe WF. Assessment of inflammatory bowel disease activity by 99m Technetium phagocyte scanning. Gastroenterology 1988;95: 989-96.
10. Dale I, Brandtzaeg P, Fagerhol MK, Scott H. Distribution of a new myelocytic antigen (L1) in human peripheral blood leukocytes. Am J Clin Pathol 1985;84:24-34.
11. Fagerhol MK, Andersson T, Naess-Andresen CF, Brandtzæg P, Dale I. Calprotectin (the L1 leukocyte protein). In: Smith VL, Dedman JR, editors. Stimulus response coupling: The role of intracellular calcium-binding proteins. Boca Raton (FL): CRC Press Inc. 1990;187-210.
12. Røseth AG, Fagerhol MK, Aadland E, Schjønsby H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992;27:793-8.
13. Aabakken L, Larsen S, Osnes M. Visual Analogue Scales for endoscopic evaluation of nonsteroidal anti-inflammatory drug-induced mucosal damage in the stomach and duodenum. Scand J Gastroenterol 1990;25:443-8.
14. Aabakken L, Osnes M. Gastroduodenal lesions induced by naproxen: an endoscopic evaluation of regional differences and natural course. Scand J Gastroenterol 1990;25:1215-22.
15. Røseth AG, Kristinsson J, Fagerhol MK, Schjønsby H, Aadland E, Nygaard K, et al. Faecal calprotectin: a novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol 1993;28: 1073-6.
16. Bjarnason I, Zanelli G, Smith T, Smethurst P, Price AB, Gumpel MJ, et al. The pathogenesis and consequence of non steroidal anti-inflammatory drug induced small intestinal inflammation in man. Scand J Rheumatol 1987 Suppl 64:55-62.
17. Bjarnason I, Fehilly B, Smethurst P, Menzies IS, Levi AJ. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man. Gut 1991;32:275-7.
18. Bjarnason I. Experimental evidence of the benefit of misoprostol beyond the stomach in humans. J Rheumatol 1990;20 Suppl:38-41.
19. 51Cr-ethylenediaminetetraacetic acid absorption test: effects of naproxen, a non-steroidal, anti-inflammatory drug. Scand J Gastroenterol 1990;25:917-24.
20. Lanza FL, Royer GL, Nelson RS. Endoscopic evaluation of the effects of aspirin, buffered aspirin and enteric-coated aspirin on gastric and duodenal mucosa. N Engl J Med 1980;303:136-8.
21. Tronstad RI, Aadland E, Holler T, Olaussen B. Gastroscopic findings after treatment with enteric-coated and plain naproxen tablets in healthy subjects. Scand J Gastroenterol 1985;20: 239-42.
22. Aabakken L, Bjørnbeth BA, Hofstad B, Olaussen B, Larsen S, Osnes M. Comparison of the gastrointestinal side effects of naproxen formulated as plain tablets, enteric coated tablets or enteric coated granules in casules. Scand J Gastroenterol 1989;24:65-73.
23. Bohbouth GE. General discussion. In: Activity related abnormalities in inflammatory bowel disease. Leiden: University Hospital, 1988;105-14.
24. Røseth AG, Aadland E, Schjønsby H, Fagerhol MK, Vatn M. Fecal calprotectin: a new marker of disease activity in IBD? Scand J Gastroenterol 1990;25 Suppl 176:103.
25. Bjarnason I, O'Morain C, Levi AJ, Peters TJ. Absorption of 51chromium-labeled ethylene-diamine-tetraacetate in inflammatory bowel disease. Gastroenterology 1983;85:318-22.
26. Bjarnason I, Williams P, So A, Zanelli GD, Levi AJ, Gumpel JM, et al. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet 1984;2:1171-4.
27. Graham DY, Smith JL, Spjut HJ, Torres E. Gastric adaptation. Studies in humans during continuous aspirin administration. Gastroenterology 1988;95:327-33.
28. Hedenbro JL, Wetterberg P, Vallengren S, Bergquist L. Lack of correlation between fecal blood loss and drug-induced gastric mucosal lesions. Gastrointest Endosc 1988;34:247-51.
29. Aabakken L, Dybdahl JH, Eidsaunet W, Haaland A, Larsen S, Osnes M. Optimal assessment of gastrointestinal side effects induced by non-steroidal anti-inflammatory drugs. Scand J Gastroenterol 1989;24:1007-13.